SYT15

gene
On this page

Also known as CHR10SYT

Summary

SYT15 (synaptotagmin 15, HGNC:17167) is a protein-coding gene on chromosome 10q11.22, encoding Synaptotagmin-15 (Q9BQS2). May be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues. It is a selective cancer dependency (DepMap: 40.0% of cell lines).

This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene.

Source: NCBI Gene 83849 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 81 total
  • Cancer dependency (DepMap): dependent in 40.0% of screened cell lines
  • MANE Select transcript: NM_031912

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17167
Approved symbolSYT15
Namesynaptotagmin 15
Location10q11.22
Locus typegene with protein product
StatusApproved
AliasesCHR10SYT
Ensembl geneENSG00000204176
Ensembl biotypeprotein_coding
OMIM608081
Entrez83849

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 7 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000374321, ENST00000374323, ENST00000374328, ENST00000449358, ENST00000503753, ENST00000512997, ENST00000907760, ENST00000907761

RefSeq mRNA: 2 — MANE Select: NM_031912 NM_031912, NM_181519

CCDS: CCDS73103, CCDS73104

Canonical transcript exons

ENST00000374321 — 8 exons

ExonStartEnd
ENSE000014631524658559846585777
ENSE000014631654658449546584615
ENSE000014631684658373246583902
ENSE000017487384658189646582191
ENSE000018010774658016446580368
ENSE000020197474657912846579175
ENSE000024884734658089446581036
ENSE000038935604658750546592064

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 78.53.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2164 / max 28.1643, expressed in 86 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1048150.112244
1048120.085637
1048130.01074
1048140.00790

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.53gold quality
right lungUBERON:000216777.45gold quality
upper lobe of left lungUBERON:000895277.18gold quality
lungUBERON:000204876.31gold quality
left uterine tubeUBERON:000130376.12gold quality
ectocervixUBERON:001224975.16gold quality
apex of heartUBERON:000209874.82gold quality
mucosa of stomachUBERON:000119973.77gold quality
lymph nodeUBERON:000002972.79gold quality
endocervixUBERON:000045872.62gold quality
subcutaneous adipose tissueUBERON:000219072.49gold quality
uterine cervixUBERON:000000272.41gold quality
placentaUBERON:000198771.95gold quality
vaginaUBERON:000099671.94gold quality
adipose tissueUBERON:000101371.80gold quality
body of pancreasUBERON:000115071.59gold quality
lower esophagus muscularis layerUBERON:003583371.51gold quality
lower esophagusUBERON:001347371.49gold quality
fallopian tubeUBERON:000388971.18gold quality
esophagogastric junction muscularis propriaUBERON:003584171.13gold quality
omental fat padUBERON:001041471.06gold quality
myometriumUBERON:000129671.04gold quality
body of uterusUBERON:000985370.96gold quality
esophagusUBERON:000104370.72gold quality
urinary bladderUBERON:000125570.65gold quality
right lobe of thyroid glandUBERON:000111970.54gold quality
tibial nerveUBERON:000132370.47gold quality
right coronary arteryUBERON:000162570.21gold quality
left coronary arteryUBERON:000162670.03gold quality
esophagus mucosaUBERON:000246969.93gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.34

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

136 targeting SYT15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-8485100.0077.574731
HSA-MIR-1252-5P100.0069.802774
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-12118100.0065.881270
HSA-MIR-3163100.0077.238605
HSA-MIR-4673100.0066.641490
HSA-MIR-5692A100.0074.406850
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-511-3P99.9968.851467
HSA-MIR-453199.9969.703181
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-7152-3P99.9767.47849
HSA-MIR-314899.9775.066478
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-590-3P99.9674.346478
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-391099.9571.132227
HSA-MIR-545-3P99.9570.742783

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 40.0% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 1)

  • molecular cloning and structure (PMID:12788067)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosyt15ENSDARG00000079926
mus_musculusSyt15ENSMUSG00000041479
rattus_norvegicusSyt15ENSRNOG00000051688

Paralogs (31): SYT7 (ENSG00000011347), SYT13 (ENSG00000019505), SYT1 (ENSG00000067715), RPH3A (ENSG00000089169), SYTL4 (ENSG00000102362), SYT17 (ENSG00000103528), SYT10 (ENSG00000110975), SYT5 (ENSG00000129990), SYT11 (ENSG00000132718), SYT4 (ENSG00000132872), SYT6 (ENSG00000134207), SYTL2 (ENSG00000137501), SYT16 (ENSG00000139973), SYTL1 (ENSG00000142765), SYT14 (ENSG00000143469), SYT2 (ENSG00000143858), SYTL5 (ENSG00000147041), SYT8 (ENSG00000149043), DOC2A (ENSG00000149927), SYTL3 (ENSG00000164674), TC2N (ENSG00000165929), SYT9 (ENSG00000170743), SYT12 (ENSG00000173227), RPH3AL (ENSG00000181031), C2CD4C (ENSG00000183186), C2CD4A (ENSG00000198535), C2CD4B (ENSG00000205502), SYT3 (ENSG00000213023), C2CD4D (ENSG00000225556), DOC2B (ENSG00000272636), SYT15B (ENSG00000277758)

Protein

Protein identifiers

Synaptotagmin-15Q9BQS2 (reviewed: Q9BQS2)

Alternative names: Chr10Syt, Synaptotagmin XV

All UniProt accessions (3): D6RF99, Q9BQS2, H3BLX3

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues.

Subunit / interactions. Homodimer.

Subcellular location. Cell membrane Cell membrane Cell membrane.

Domain organisation. Neither C2 domains mediates Ca(2+)-dependent or -independent phospholipid binding.

Similarity. Belongs to the synaptotagmin family.

Isoforms (4)

UniProt IDNamesCanonical?
Q9BQS2-11, Syt XV-ayes
Q9BQS2-22, Syt XV-b
Q9BQS2-33
Q9BQS2-44

RefSeq proteins (2): NP_114118, NP_852660 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000008C2_domDomain
IPR035892C2_domain_sfHomologous_superfamily
IPR047897Synaptotagmin-15/17_C2ADomain

Pfam: PF00168

UniProt features (13 total): splice variant 4, topological domain 2, sequence conflict 2, domain 2, chain 1, transmembrane region 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BQS2-F177.250.52

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 68 (showing top): GOBP_REGULATION_OF_EXOCYTOSIS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_EXOCYTOSIS, GOBP_SECRETION, GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY, GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS, GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS, GOBP_REGULATION_OF_TRANSPORT, GOCC_EXOCYTIC_VESICLE, GOCC_SECRETORY_VESICLE, GOMF_SNARE_BINDING, GOMF_LIPID_BINDING, GOMF_PHOSPHOLIPID_BINDING, GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING

GO Biological Process (2): vesicle-mediated transport (GO:0016192), regulation of calcium ion-dependent exocytosis (GO:0017158)

GO Molecular Function (4): SNARE binding (GO:0000149), calcium-dependent phospholipid binding (GO:0005544), calcium ion sensor activity (GO:0061891), protein binding (GO:0005515)

GO Cellular Component (3): plasma membrane (GO:0005886), exocytic vesicle (GO:0070382), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport1
cellular process1
calcium-ion regulated exocytosis1
regulation of regulated secretory pathway1
protein binding1
phospholipid binding1
calcium ion binding1
metal ion sensor activity1
binding1
membrane1
cell periphery1
transport vesicle1
secretory vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

342 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SYT15GPRIN2O60269537
SYT15ANTXRLA6NF34482
SYT15NPY4R2P0DQD5399
SYT15ASB14A6NK59384
SYT15FRMPD2Q68DX3380
SYT15AGAP6Q5VW22380
SYT15KNCNA6PVL3369
SYT15TMEM161AQ9NX61363
SYT15ALG14Q96F25359
SYT15SNAP25P13795357
SYT15COLQQ9Y215330
SYT15FAM25AB3EWG3324
SYT15ASAH2BP0C7U1322
SYT15RAPSNQ13702316
SYT15ZNF510Q9Y2H8311

IntAct

2 interactions, top by confidence:

ABTypeScore
NEK4E2F8psi-mi:“MI:0914”(association)0.350

BioGRID (15): SYT15 (Affinity Capture-MS), SYT15 (Two-hybrid), LOC102724488 (Two-hybrid), SYT15 (Two-hybrid), LOC102724488 (Two-hybrid), SYT15 (Two-hybrid), LOC102724488 (Two-hybrid), SYT15 (Two-hybrid), LOC102724488 (Two-hybrid), SYT15 (Two-hybrid), LOC102724488 (Two-hybrid), SYT15 (Affinity Capture-MS), SYT15 (Affinity Capture-MS), C6orf211 (Cross-Linking-MS (XL-MS)), SYT15 (Affinity Capture-RNA)

ESM2 similar proteins: A0A0B4J1F4, A0A0G2JXN2, A2AWP8, A2RRH5, C9J798, O43374, O70277, O95294, P04629, P59926, Q0GA42, Q13368, Q14318, Q16512, Q29RM4, Q2HY40, Q2T9P3, Q2TBA3, Q5BIM1, Q5M7W1, Q5R5M3, Q5R811, Q5T7P8, Q5XIS9, Q62746, Q6PFQ7, Q6PFY8, Q7TNM2, Q7TP90, Q7Z4K8, Q8BG60, Q8BHT7, Q8BQC3, Q8C6N3, Q8CIW5, Q8IZ69, Q8NCT1, Q920N2, Q92546, Q925B4

Diamond homologs: A0A075F932, A0FGR8, A4IJ05, K8FE10, O00445, O00750, O08625, O08835, O35681, O43581, P04409, P05128, P05129, P05130, P05696, P10102, P10829, P13677, P17252, P20444, P21521, P21579, P21707, P24505, P24506, P24507, P29101, P34693, P40748, P40749, P41823, P41885, P46096, P46097, P47191, P47708, P47709, P47861, P48018, P50232

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance64
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1759 predictions. Top by Δscore:

VariantEffectΔscore
10:46582190:C:CAdonor_loss1.0000
10:46582191:A:ATdonor_loss1.0000
10:46582192:TACCT:Tdonor_loss1.0000
10:46582193:GTACC:Gdonor_loss1.0000
10:46582194:TGTA:Tdonor_loss1.0000
10:46583729:C:CCacceptor_gain1.0000
10:46583729:C:Tacceptor_gain1.0000
10:46583730:CC:Cacceptor_gain1.0000
10:46583731:AC:Aacceptor_gain1.0000
10:46583732:CAC:Cacceptor_gain1.0000
10:46583732:CACC:Cacceptor_gain1.0000
10:46583733:ACAC:Aacceptor_gain1.0000
10:46583734:GACAC:Gacceptor_gain1.0000
10:46583796:T:TAdonor_gain1.0000
10:46583899:T:TAdonor_gain1.0000
10:46583901:C:Adonor_loss1.0000
10:46583902:AC:Adonor_loss1.0000
10:46583902:ACCTC:Adonor_loss1.0000
10:46583903:TACCT:Tdonor_loss1.0000
10:46583904:ATAC:Adonor_loss1.0000
10:46583905:CATA:Cdonor_loss1.0000
10:46584481:A:Tacceptor_gain1.0000
10:46584482:C:CTacceptor_gain1.0000
10:46584492:C:CAacceptor_loss1.0000
10:46584492:C:CCacceptor_gain1.0000
10:46584493:GC:Gacceptor_loss1.0000
10:46584493:GCTG:Gacceptor_loss1.0000
10:46584495:GGG:Gacceptor_gain1.0000
10:46584496:GGGG:Gacceptor_gain1.0000
10:46584497:GGGGG:Gacceptor_gain1.0000

AlphaMissense

2736 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:46585607:T:AV318D0.996
10:46587573:T:AW398R0.995
10:46587573:T:CW398R0.995
10:46587534:G:CG385R0.994
10:46587575:G:CW398C0.994
10:46587575:G:TW398C0.994
10:46584517:T:CL282P0.993
10:46585650:G:CK332N0.993
10:46585650:G:TK332N0.993
10:46585619:T:CL322P0.992
10:46585706:T:CF351S0.992
10:46587535:G:AG385D0.992
10:46584529:T:CL286P0.991
10:46584556:T:CL295P0.991
10:46587615:T:AW412R0.991
10:46587615:T:CW412R0.991
10:46584562:T:AV297E0.990
10:46585742:T:CL363P0.990
10:46585738:A:CS362R0.989
10:46585740:C:AS362R0.989
10:46585740:C:GS362R0.989
10:46587574:G:CW398S0.989
10:46585705:T:CF351L0.988
10:46585707:C:AF351L0.988
10:46585707:C:GF351L0.988
10:46582031:T:CL164P0.987
10:46584553:G:CR294P0.987
10:46584568:T:AV299E0.987
10:46587535:G:TG385V0.987
10:46585748:T:CL365P0.986

dbSNP variants (sampled 300 via entrez): RS10545241 (10:46594606 AGAC>A), RS10588658 (10:46580719 CGTGTGTGT>C,CGT,CGTGT,CGTGTGT,CGTGTGTGTGT), RS10588659 (10:46580680 CTGTGTGTGTGTGTGTGTGTGTGTGTG>C,CTG,CTGTG,CTGTGTGTG,CTGTGTGTGTGTG,CTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG), RS10712659 (10:46586841 CAAAAA>C,CAA,CAAA,CAAAA,CAAAAAA,CAAAAAAAAA), RS111273873 (10:46578735 A>G), RS111596780 (10:46586805 A>C,G), RS111625798 (10:46579453 C>A,T), RS111852046 (10:46584752 C>T), RS111926928 (10:46579627 G>T), RS112001859 (10:46578821 C>T), RS11204657 (10:46592826 C>G), RS112255958 (10:46589134 G>A), RS112965082 (10:46583722 TC>T,TCC,TCCC), RS113324281 (10:46584716 A>C), RS113796296 (10:46584214 C>A,T)

Disease associations

OMIM: gene MIM:608081 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
bisphenol Adecreases expression1
2,5,2’,5’-tetrachlorobiphenylincreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
sodium arseniteincreases expression1
Dasatinibincreases expression1
Resveratrolaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Benzo(a)pyrenedecreases methylation1
Copperaffects cotreatment, decreases expression1
Folic Aciddecreases expression1
Glucoseincreases expression1
Smokeincreases expression1
Thalidomidedecreases expression1
Tobacco Smoke Pollutionincreases methylation1
Tretinoinincreases expression1
Urethanedecreases expression1
Valproic Acidincreases methylation1
Acrylamidedecreases expression1
S-Nitrosoglutathionedecreases expression1
Particulate Matterincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.